Novel therapies and diagnostic tools in neurogenetic disorders

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1073323

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Friedreich ataxia, a life-shortening neurologic condition, has no proven treatment. This study will assess a medication called resveratrol in 60 individuals in centres in four Australian states. The second study will explore the effectiveness of an emerging imaging technique, high-resolution nerve ultrasound, in the diagnosis and monitoring of conditions that affect the nerves in childhood.

Funded Activity Details

Start Date: 01-01-2014

End Date: 01-01-2019

Funding Scheme: Early Career Fellowships

Funding Amount: $190,049.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Neurology and Neuromuscular Diseases

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Charcot-Marie-Tooth disease | Friedreich ataxia | antioxidant therapy | clinical trial | natural history | neurogenetics | paediatric | ultrasound

Related Links